Specian, Ana Flavia L. ; Serpeloni, Juliana M. ; Tuttis, Katiuska ; Ribeiro, Diego L. ; Ciliao, Heloisa L. ; Varanda, Eliana A. ; Sannomiya, Miriam ; Martinez-Lopez, Wilner ; Vilegas, Wagner ; Colus, Ilce M. S.
Número total de Autores: 10
|Tipo de documento:||Artigo Científico|
|Fonte:||Cytotechnology; v. 68, n. 6, p. 2729-2744, DEC 2016.|
|Citações Web of Science:||7|
Brazilian flora biodiversity has been widely investigated to identify effective and safe phytotherapeutic compounds. Among the investigated plant species, the Byrsonima genus exhibits promising biological activities. This study aimed at evaluating the cytotoxicity of B. correifolia, B. verbascifolia, B. fagifolia and B. intermedia extracts using different assays in two cell lines (primary gastric and HepG2 cells). The different extract concentrations effects on cell viability were assayed using the MTT, aquabluer, neutral red and LDH assays. Non-cytotoxic concentrations were selected to generate cell proliferation curves and to assess cell cycle kinetics by flow cytometry. Byrsonima extracts differentially affected cell viability depending on the metabolic cellular state and the biological parameter evaluated. B. fagifolia and B. intermedia extracts exhibited lower cytotoxic effects than B. correifolia and B. verbascifolia in all assays. The results obtained with LDH and flow cytometry assays were more reliable, suggesting that they can be useful in the screening for herbal medicine and to further characterize these extracts as phytotherapeutic compounds. (AU)
|Processo FAPESP:||09/52237-9 - Fitoterápicos padronizados como alvo para o tratamento de doenças crônicas|
|Linha de fomento:||Auxílio à Pesquisa - Programa BIOTA - Temático|